The Complexities of Stable Ischemic Heart Disease and Its Treatment will explore the changing perspectives on SIHD, including a refined understanding of the diverse pathologic underpinnings of the condition and the drivers of disease progression. Such an analysis must begin with an understanding of how predisposing risk factors can lead to early symptomatic disease. New findings have revealed that symptomatic SIHD actually constitutes a spectrum of pathophysiologic and clinical manifestations encompassing stenotic (macrovascular), non-stenotic (microvascular), and nonvascular aspects of myocardial ischemia. This refined understanding about the pathobiology of SIHD and its range of presentations will lead to improved diagnoses of SIHD patients with atypical symptoms. It has also reframed the essential elements of diagnosis and ischemic risk assessment, particularly the importance of functional ischemic assessment in driving treatment decisions.
There is a growing recognition that optimal patient care involves primary prevention, patient-centered management of symptomatic SIHD, and secondary prevention. These insights are also reinforced by key clinical trial data and the practice guidelines, which call for guideline-directed medical therapy (GDMT) as first-line therapy for SIHD, rather than preemptive revascularization. This CME-certified program will address these issues and reinforce the point that treatment options should be based on the ischemic burden, with revascularization as an option in patients with a moderate to extensive ischemia who remain symptomatic despite GDMT.
Deepak L. Bhatt, MD, MPH
Executive Director, Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart & Vascular Center
Professor of Medicine
Harvard Medical School
David A. Morrow, MD, MPH
Director, Levine Cardiac Intensive Care Unit
Cardiovascular Division, Brigham and Women's Hospital
Senior Investigator, TIMI Study Group
Associate Professor of Medicine
Harvard Medical School
The target audience for this activity is community cardiologists, interventional cardiologists, and other professionals who treat patients with stable ischemic heart disease (SIHD).
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Adhere to guidelines-recommended approaches in the diagnosis and risk assessment of SIHD patients
- Adopt evidence-based risk assessment strategies to identify high-risk patients who are likely to benefit from intensive therapies and revascularization options
- Understand the management of persistent or recurrent angina in patients who have been revascularized
|Lunch & CME Program:
||12:30pm – 1:30pm
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 - 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test or evaluation, please email email@example.com.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Method of Participation
To complete the activity and receive credit, the participant must attend the live program and complete the evaluation form. A CME certificate will be emailed following the program or distributed onsite.
There are no fees associated with this program.
Event staff will be glad to assist you with any specials needs (e.g. physical, dietary, etc.). Please email firstname.lastname@example.org at least 5 days prior to the scheduled program.
Jointly Sponsored By
|Jointly provided by Potomac Center for Medical Education and Rockpointe
Supported by an independent educational grant from Gilead Sciences Medical Affairs.
By clicking the Registration Button below you are agreeing that you have read and understood the CME/CE Statements above.
Registration is for planning purposes only. Seating is limited and will be provided on a first-come, first-served basis.
Click here to view the presentation slides from this CME-certified series held at select American College of Cardiology state chapter meetings during the Fall of 2014.